Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
151-165 of 2102 results
Concordia Healthcare to buy Amdipharm Mercury for $3.5bn
By PBR Staff Writer
Concordia Healthcare has agreed to acquire the UK-based pharmaceutical firm Amdipharm Mercury from Cinven for $3.5bn.
Contract Research & Services > Contract Research > News
Novo Nordisk, MIT to undertake research on next generation of drug delivery devices
By PBR Staff Writer
Novo Nordisk and the Langer Laboratory at the Massachusetts Institute of Technology (MIT) have collaborated to undertake research on the next generation of drug delivery devices for the administration of peptides.
Contract Research & Services > Contract Research > News
Recipharm negotiates with Alcon on manufacturing deal
Recipharm is currently in discussions with Alcon and has reached agreement in principle to enter into a long-term manufacturing agreement for a range of ophthalmology products.
Contract Research & Services > Contract Research > News
AMRA and Pfizer form novel research alliance
By PBR Staff Writer
AMRA and Pfizer have collaborated with the aim of potentially identifying patients most at risk from metabolic disease and comorbidities.
Contract Research & Services > Contract Research > News
Aerie Pharmaceuticals and Ramot at Tel Aviv University form research collaboration
Aerie Pharmaceuticals and Ramot at Tel Aviv University, Tel Aviv University's technology transfer company, formed a research collaboration and license agreement for a preclinical anti-beta amyloid small molecule product candidate for neuroprotection and dry age-related macular degeneration (dry AMD).
Contract Research & Services > Contract Research > News
International Stem Cell enters into second phase of research deal with Rohto Pharmaceutical
International Stem Cell Corporation has entered into the second phase of the existing research agreement with Rohto Pharmaceutical.
Contract Research & Services > Contract Research > News
Sanofi and Google partner to improve diabetes treatment
Sanofi and Google will work together on new digital technology and tools for enhancing the management and treatment of diabetes.
Contract Research & Services > Contract Research > News
ESC launches new concept for driving innovation in cardiovascular research with support from Boehringer
The European Society of Cardiology (ESC) announced the launch of the competitive medical research programme ‘ESC Grants for Medical Research Innovation’, exclusively supported by an independent grant from Boehringer Ingelheim.
Contract Research & Services > Contract Research > News
WuXi PharmaTech's STA subsidiary gets first approval from Japanese regulatory authorities
WuXi PharmaTech (Cayman), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, announced that its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical (STA) received its first approval from the Japan PMDA for the manufacture of the GMP intermediate of a branded commercial drug in July.
Contract Research & Services > Contract Research > News
Biolab to open new R&D centre in Greater Toronto Area
By PBR Staff Writer
Brazilian pharmaceutical firm Biolab Farmacêutica is opening a new research and development (R&D) centre in the Greater Toronto Area in Canada.
Contract Research & Services > Contract Research > News
Enumeral, UMass Medical School enter into research study agreement
Enumeral Biomedical Holdings (ENUM) announced that it has entered into a research study agreement with University of Massachusetts Medical School (UMMS), which includes that institution’s clinical partner, UMass Memorial Health Care, Inc.
Contract Research & Services > Contract Research > News
Clementia enrols children in ongoing Phase II trial of palovarotene to treat FOP
By PBR Staff Writer
Canada-based Clementia Pharmaceuticals has started enrolling children aged six years in its ongoing Phase II trial of palovarotene to treat fibrodysplasia ossificans progressiva (FOP), an extremely rare and severely disabling congenital myopathy.
Contract Research & Services > Contract Research > News
Arbutus begins dosing in Phase IIa expansion group trial of TKM-PLK1 to treat HCC
By PBR Staff Writer
Canadian biopharmaceutical firm Arbutus Biopharma has started dosing in a 20 subject expansion group of a Phase IIa clinical trial of TKM-PLK1 for the treatment of hepatocellular carcinoma (HCC).
Contract Research & Services > Contract Research > News
CSL Behring begins enrollment in Phase II/III trial of rVIIa-FP to treat hemophilia A or B
By PBR Staff Writer
CSL Behring has started enrolling patients in its Phase II/III clinical trial of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B.
Contract Research & Services > Contract Research > News
Eisai reports positive Phase III trial results for FYCOMPA
Eisai announced that the results of its Phase 3 trial (Study 332) for FYCOMPA (perampanel) CIII have been published in the online edition of Neurology, the medical journal of the American Academy of Neurology.
Contract Research & Services > Contract Research > News
151-165 of 2102 results